In this study, we evaluated the role of KLRB1 as a potential independent prognostic biomarker by studying its association with the clinicopathologic features of BC and clarified the influence of KLRB1 on patient survival using public datasets from The Cancer Genome Atlas (TCGA) database. The gene discussed is KLRB1; the disease is breast cancer.